Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: Findings from the SABA use IN Asthma (SABINA) study in Asia

Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: Findings from the SABA use IN Asthma (SABINA) study in Asia

Background: The extent of short-acting Beta-2-agonist (β2-agonist) (SABA) use across Asian countries is not well documented. As part of the SABA use IN Asthma (SABINA) III study, we assessed SABA prescriptions and clinical outcomes in patients with asthma from Asia. Methods: This cross-sectional stu...

Full description

Bibliographic Details
Main Authors: Hao-Chien Wang, MD PhD, Susanthy Djajalaksana, MD, Latha Sharma, MD, Theerakorn Theerakittikul, MD, Hui Fang Lim, MBBS, Kwang Ha Yoo, MD, Andrea Ban Yu-Lin, MMED, Dina V. Diaz, MD, Lala Yang, Master, Maarten J.H.I. Beekman, MD
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:World Allergy Organization Journal
Subjects:
Asia
Asthma
Prescriptions
Public health
Adrenergic beta-2 receptor agonists
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455123000832

Internet

http://www.sciencedirect.com/science/article/pii/S1939455123000832

Similar Items